4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-20-000055
Sr. VP & Chief Medical Officer gave up 1,540 shares (to pay taxes)
- Sr. VP & Chief Medical Officer acquired 5,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Adda Nathalie · Sr. VP & Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-15 | Exercise or conversion : show line 1 in the form | +5,250 | 28,484 | D | ||
| 2020-12-15 | Shares withheld for taxes : show line 2 in the form | −1,540 | $42.52 | $65,481 | 26,944 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-15 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −5,250 | 0 | D |
Loading xslF345X03/edgar.xml…